Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …

Current evidence on COVID-19 prognostic models is inconsistent and clinical applicability
remains controversial. We performed a systematic review to summarize and critically …

Rationale and Objectives To evaluate the impact of low skeletal muscle mass in patients
with COVID-19 on relevant outcomes like 30-day mortality, need for intubation and need for …

Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of
patients with heart failure (HF). Several consensus documents describe the appropriate …

Background Low skeletal muscle mass (LSMM) and visceral fat areas can be assessed by
cross‐sectional images. These parameters are associated with several clinically relevant …

Abstract Coronavirus disease 19 (COVID-19) may present as a multi-organ disease with a
hyperinflammatory and prothrombotic response (immunothrombosis) in addition to upper …

Introduction: The appraisal of disease severity and prediction of adverse outcomes using
risk stratification tools at early disease stages is crucial to diminish mortality from coronavirus …

Purpose Chest computed tomography (CT) is a high-sensitivity diagnostic tool for depicting
interstitial pneumonia and may lay a critical role in the evaluation of the severity and extent …

Background/Aim: Epicardial adipose tissue (EAT) has been established as a quantitative
imaging biomarker associated with the prognosis of several diseases, especially …

Background Thoracal lymphadenopathy may predict prognosis in patients with coronavirus
disease 2019 (COVID-19), albeit the reported data is inconclusive. The aim of the present …